Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2020
Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8<sup>+</sup> T cell stemness and antitumor immunity
Dalton Hermans, Sanjivan Gautam, Juan C García-Cañaveras, et al.
Cell Reports. Medicine
|
July 1, 2021
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
Nan Li, Madeline B Torres, Madeline R Spetz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 3, 2026
Development of novel GPC2-directed radiotheranostics and CAR T-cell therapy for neuroblastoma
Ira Phadke, Divya Nambiar, George Diehl, et al.
Molecular Cancer Therapeutics
|
February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors
Jeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Cancers
|
September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Cell Reports. Medicine
|
June 23, 2026
A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling
Constanza Rodriguez, Robert S Edinger, George Diehl, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitors
Thomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.
Journal for Immunotherapy of Cancer
|
July 1, 2026
ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma
Reona Okada, Arnulfo Mendoza, Darryl Nousome, et al.
Nature Communications
|
July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2020
Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8<sup>+</sup> T cell stemness and antitumor immunity
Dalton Hermans, Sanjivan Gautam, Juan C García-Cañaveras, et al.
Cell Reports. Medicine
|
July 1, 2021
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
Nan Li, Madeline B Torres, Madeline R Spetz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 3, 2026
Development of novel GPC2-directed radiotheranostics and CAR T-cell therapy for neuroblastoma
Ira Phadke, Divya Nambiar, George Diehl, et al.
Molecular Cancer Therapeutics
|
February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors
Jeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Cancers
|
September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Cell Reports. Medicine
|
June 23, 2026
A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling
Constanza Rodriguez, Robert S Edinger, George Diehl, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitors
Thomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.
Journal for Immunotherapy of Cancer
|
July 1, 2026
ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma
Reona Okada, Arnulfo Mendoza, Darryl Nousome, et al.
Nature Communications
|
July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Page
of 6